Clinical trials sponsored by InSightec

Phase breakdown

Conditions studied

Recruiting trials led by InSightec

• A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
  NCT05539196 · Phase: Not specified · Ages: 30 Years to 99 Years · Sex: All (male and female) · 5 locations
• A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
  NCT04991831 · Phase: Not specified · Ages: 30 Years to 99 Years · Sex: All (male and female) · 8 locations
• Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
  NCT05317858 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 14 locations
• ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
  NCT03671889 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 85 Years · Sex: All (male and female) · 10 locations
• MR-guided Focused Ultrasound Plus GCase
  NCT05565443 · Phase: Not applicable (e.g. observational or device study) · Ages: 35 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is InSightec recruiting for?

InSightec is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.